Farms.com Home   News

Report raises doubts on California dairy digester costs

By Farms.com

The financial sustainability of California's initiative to lower methane emissions from dairy farms through anaerobic digesters has been challenged in a report by the Center for Food Safety. Conducted by Kevin Fingerman of Cal Poly Humboldt, the analysis reveals that the Dairy Digester Research and Development Program's costs could be 17 times the state and industry's estimates. 

California has allocated approximately $200 million towards this endeavor between 2015 and 2022, aiming for a substantial decrease in methane emissions. However, the report suggests a discrepancy in cost-effectiveness, with actual expenses ballooning to $159 per ton of CO2 reduced, far exceeding the state's $9 per ton estimate. 

This revelation stirs debate about the allocation of taxpayer money, especially as the program appears to predominantly benefit large agribusinesses and investors.  

Despite criticisms, the California Department of Food and Agriculture counters by highlighting the ecological benefits of dairy digesters, such as their role in generating renewable energy and preventing worse environmental outcomes. 

The state contends that supporting sustainable practices across dairy farms is crucial, even as it faces scrutiny over the program's cost and its impact on agricultural practices and the environment.


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.